Press Releases Spineway

Equities

Market Closed - Euronext Paris Other stock markets 09:05:25 29/04/2024 pm IST			5-day change	1st Jan Change
0.8 ^EUR	-6.43%		-22.32%	-88.24%

17/04	Spineway: punished despite a solid first quarter	CF
16/04	Spineway SA Announces Revenue Results for the First Quarter of 2024	CI

Growth of 28% of 2024 first quarter revenue	16/04	AQ
2023 Shareholders General Meeting	27/03	AQ
Reverse stock split	29/02	AQ
Preparatory documents for the General Meeting as of of March 25, 2024	19/02	AQ
SPINEWAY : 2023 annual results	07/02	AQ
Increase of 2023 revenue at €10.5 million	25/01	AQ
Shares reverse split	05/01	AQ
SPINEWAY : International rollout of the VEOS implant range - First implants in Spain - New approvals in Colombia and Indonesia	24/11	AQ
Extraordinary General Meeting's minute	13/11	AQ
Deputy Chief Executive Officer's appointment	07/11	AQ
US 2023 NASS conference : VEOS System	02/11	AQ
Spineway : Document AMF CP. 2023E935253	27/23/27	PU
Spineway : Document AMF CP. 2023E934680	25/23/25	PU
Spineway : Document AMF CP. 2023E934420	24/23/24	PU
VEOS FDA 510(k) clearance	19/23/19	AQ
Spineway : Document AMF CP. 2023E933058	16/23/16	PU
Revenue growth as of September 2023 by 40%	13/23/13	AQ
INTERNATIONAL MASTERCLASS	14/23/14	AQ
First-half 2023 revenue of € 5.4 million (+75%)	11/23/11	AQ
Strengthening of the cash position thanks to new financing	25/23/25	AQ

No results for this search